Experimental study of immunotropic properties of metabolites of <i>Bacillus subtilis B-9909</i> strain, promising in the formulation of a new hepatoprotector

This brief report is devoted to the experimental study of the immunotropic activity of a new compound, a metabiotic, based on metabolites (biologically active substances, BAS) produced by the saprophytic and safe standardized strain of Bacillus subtilis B-9909. The aim of the study was to experiment...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριος συγγραφέας: N. А. Zabokritskiy
Μορφή: Άρθρο
Γλώσσα:Russian
Έκδοση: St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2023-06-01
Σειρά:Медицинская иммунология
Θέματα:
Διαθέσιμο Online:https://www.mimmun.ru/mimmun/article/view/2772
_version_ 1826534090026778624
author N. А. Zabokritskiy
author_facet N. А. Zabokritskiy
author_sort N. А. Zabokritskiy
collection DOAJ
description This brief report is devoted to the experimental study of the immunotropic activity of a new compound, a metabiotic, based on metabolites (biologically active substances, BAS) produced by the saprophytic and safe standardized strain of Bacillus subtilis B-9909. The aim of the study was to experimentally evaluate the immunotropic effect of metabolites produced by probiotic microorganisms of the genus Bacillus of the culture of probiotic microorganisms of the Bacillus subtilis B-9909 on laboratory animals when modeling their toxic lesion. Metabolites were isolated from the culture fluid of the bacterial culture Bacillus subtilis, strain RNCIM (Russian National Collection of Industrial Microorganisms) B-9909, during its deep cultivation in a medium consisting of hydrochloric acid hydrolysate of soy flour or pancreatic hydrolysate of casein. The study of humoral status indicators in experimental groups of animals in assessing the therapeutic efficacy of an experimental metabiotic sample, in relation to the group receiving the ursosan comparison drug, was carried out by determining such quantitative serum parameters as the titers of immunoglobulins M, G, A, E, the IFNa titer and the concentration of circulating immune complexes. Liver damage was studied by modeling acute toxic hepatitis in white rats. Thus, the studies conducted to study the humoral status of laboratory animals receiving metabolites produced by probiotic microorganisms of the genus Bacillus of the culture of probiotic microorganisms of the Bacillus subtilis B-9909 on laboratory animals when modeling toxic damage in them, give grounds to conclude that the test sample of BAS has a significant immunomodulatory effect, in comparison with ursosan. This circumstance allows us to recommend this compound as promising for the creation of a new hepatoprotector drug candidate with an immunotropic effect.
first_indexed 2024-03-08T05:46:56Z
format Article
id doaj.art-b705fcd87f6a4d44a89934c6dd4b3f03
institution Directory Open Access Journal
issn 1563-0625
2313-741X
language Russian
last_indexed 2025-03-14T02:17:29Z
publishDate 2023-06-01
publisher St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
record_format Article
series Медицинская иммунология
spelling doaj.art-b705fcd87f6a4d44a89934c6dd4b3f032025-03-11T17:59:14ZrusSt. Petersburg branch of the Russian Association of Allergologists and Clinical ImmunologistsМедицинская иммунология1563-06252313-741X2023-06-0125360160410.15789/1563-0625-ESO-27721666Experimental study of immunotropic properties of metabolites of <i>Bacillus subtilis B-9909</i> strain, promising in the formulation of a new hepatoprotectorN. А. Zabokritskiy0Institute of Immunology and Physiology, Ural Branch, Russian Academy of SciencesThis brief report is devoted to the experimental study of the immunotropic activity of a new compound, a metabiotic, based on metabolites (biologically active substances, BAS) produced by the saprophytic and safe standardized strain of Bacillus subtilis B-9909. The aim of the study was to experimentally evaluate the immunotropic effect of metabolites produced by probiotic microorganisms of the genus Bacillus of the culture of probiotic microorganisms of the Bacillus subtilis B-9909 on laboratory animals when modeling their toxic lesion. Metabolites were isolated from the culture fluid of the bacterial culture Bacillus subtilis, strain RNCIM (Russian National Collection of Industrial Microorganisms) B-9909, during its deep cultivation in a medium consisting of hydrochloric acid hydrolysate of soy flour or pancreatic hydrolysate of casein. The study of humoral status indicators in experimental groups of animals in assessing the therapeutic efficacy of an experimental metabiotic sample, in relation to the group receiving the ursosan comparison drug, was carried out by determining such quantitative serum parameters as the titers of immunoglobulins M, G, A, E, the IFNa titer and the concentration of circulating immune complexes. Liver damage was studied by modeling acute toxic hepatitis in white rats. Thus, the studies conducted to study the humoral status of laboratory animals receiving metabolites produced by probiotic microorganisms of the genus Bacillus of the culture of probiotic microorganisms of the Bacillus subtilis B-9909 on laboratory animals when modeling toxic damage in them, give grounds to conclude that the test sample of BAS has a significant immunomodulatory effect, in comparison with ursosan. This circumstance allows us to recommend this compound as promising for the creation of a new hepatoprotector drug candidate with an immunotropic effect.https://www.mimmun.ru/mimmun/article/view/2772metabioticbacillus subtilismetabolitesprobioticimmunotropic activityhumoral immunityhepatotoxicityhepatoprotector
spellingShingle N. А. Zabokritskiy
Experimental study of immunotropic properties of metabolites of <i>Bacillus subtilis B-9909</i> strain, promising in the formulation of a new hepatoprotector
Медицинская иммунология
metabiotic
bacillus subtilis
metabolites
probiotic
immunotropic activity
humoral immunity
hepatotoxicity
hepatoprotector
title Experimental study of immunotropic properties of metabolites of <i>Bacillus subtilis B-9909</i> strain, promising in the formulation of a new hepatoprotector
title_full Experimental study of immunotropic properties of metabolites of <i>Bacillus subtilis B-9909</i> strain, promising in the formulation of a new hepatoprotector
title_fullStr Experimental study of immunotropic properties of metabolites of <i>Bacillus subtilis B-9909</i> strain, promising in the formulation of a new hepatoprotector
title_full_unstemmed Experimental study of immunotropic properties of metabolites of <i>Bacillus subtilis B-9909</i> strain, promising in the formulation of a new hepatoprotector
title_short Experimental study of immunotropic properties of metabolites of <i>Bacillus subtilis B-9909</i> strain, promising in the formulation of a new hepatoprotector
title_sort experimental study of immunotropic properties of metabolites of i bacillus subtilis b 9909 i strain promising in the formulation of a new hepatoprotector
topic metabiotic
bacillus subtilis
metabolites
probiotic
immunotropic activity
humoral immunity
hepatotoxicity
hepatoprotector
url https://www.mimmun.ru/mimmun/article/view/2772
work_keys_str_mv AT nazabokritskiy experimentalstudyofimmunotropicpropertiesofmetabolitesofibacillussubtilisb9909istrainpromisingintheformulationofanewhepatoprotector